UnitedHealth (UNH) is a publicly traded Healthcare sector company. As of May 20, 2026, UNH trades at $381.80 with a market cap of $355.20B and a P/E ratio of 28.68. UNH moved -1.50% today. Year to date, UNH is +15.71%; over the trailing twelve months it is +23.22%. Its 52-week range spans $234.60 to $630.73. Analyst consensus is buy with an average price target of $388.68. Rallies surfaces UNH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
UnitedHealth Shares Fall 5.3% After Berkshire Exit and CEO Trial Evidence: UnitedHealth shares slid as much as 5.3% after Berkshire Hathaway liquidated its entire 5.04 million‐share position rebuilt less than a year earlier. Prosecutors introduced evidence in Luigi Mangione’s trial for the fatal shooting of UnitedHealthcare CEO Brian Thompson, heightening concerns over executive succession.
| Metric | Value |
|---|---|
| Price | $381.80 |
| Market Cap | $355.20B |
| P/E Ratio | 28.68 |
| EPS | $13.28 |
| Dividend Yield | 2.21% |
| 52-Week High | $630.73 |
| 52-Week Low | $234.60 |
| Volume | 6.25M |
| Avg Volume | 0 |
| Revenue (TTM) | $449.71B |
| Net Income | $12.81B |
| Gross Margin | 88.64% |
23 analysts cover UNH: 0 strong buy, 18 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $388.68.